Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KAVITA S VYAS

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1346246964
CMS profile
333610
Location
NACOGDOCHES, TX

General Payments · PY2018–2024

$2,830.60

  • Reported across 157 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$286.47

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $286.47 15

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $715.82 30
PY2019 $366.53 19
PY2020 $307.50 21
PY2021 $553.93 38
PY2022 $221.88 13
PY2023 $378.47 21
PY2024 $286.47 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $13.20 06/28/2024 Food and Beverage Undisputed 01/23/2026 1124998489 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.56 04/03/2024 Food and Beverage Undisputed 01/23/2026 1086160082 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.86 10/28/2024 Food and Beverage Undisputed 01/23/2026 1086202534 CMS
Boston Scientific Corporation $24.83 06/24/2024 Food and Beverage Undisputed 01/23/2026 1092608772 CMS
Dexcom, Inc. $30.28 04/10/2024 Food and Beverage Undisputed 01/23/2026 1153313435 CMS
E.R. Squibb & Sons, L.L.C. $16.66 01/17/2024 Food and Beverage Undisputed 01/23/2026 1101618141 CMS
GlaxoSmithKline, LLC. $13.39 02/01/2024 Food and Beverage Undisputed 01/23/2026 1116581255 CMS
Lilly USA, LLC $17.89 02/19/2024 Food and Beverage Undisputed 01/23/2026 1135123367 CMS
Lilly USA, LLC $19.08 04/12/2024 Food and Beverage Undisputed 01/23/2026 1135112878 CMS
Novo Nordisk Inc $15.87 09/11/2024 Food and Beverage Undisputed 01/23/2026 1096891661 CMS
Otsuka America Pharmaceutical, Inc. $18.96 02/05/2024 Food and Beverage Undisputed 01/23/2026 1119001035 CMS
Otsuka America Pharmaceutical, Inc. $19.55 02/06/2024 Food and Beverage Undisputed 01/23/2026 1119001037 CMS
Otsuka America Pharmaceutical, Inc. $19.60 03/27/2024 Food and Beverage Undisputed 01/23/2026 1119001039 CMS
Otsuka America Pharmaceutical, Inc. $17.92 04/24/2024 Food and Beverage Undisputed 01/23/2026 1119001041 CMS
Sumitomo Pharma America, Inc. $18.82 10/29/2024 Food and Beverage Undisputed 01/23/2026 1148932440 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.